{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2004"],"condition":["Neoplasm Metastasis","Chemotherapy","Liver Metastases","Colorectal Cancer","Colorectal Neoplasms","Liver Neoplasms"],"disease":["Neoplasm Metastasis","Chemotherapy","Liver Metastases","Colorectal Cancer","Colorectal Neoplasms","Liver Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2020119"],"location":["France"],"study_start_month":["4"],"keyword":["Oxaliplatin","Folfirinox","Leucovorin","Fluorouracil"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Intensified Chemotherapy in CRC After Resection of Liver Metastases","description":"Randomized, open label, multicentre phase II trial followed by phase III comparing overall survival after having selected the best experimental arm.","dates":{"creation":"2004-04-15"},"accession":"2020119","cross_references":{"ClinicalTrials___gov":["NCT00208260"]}}